Ledger.Open graph →
SEC Form D · filed August 23, 2021

EYEGATE PHARMACEUTICALS INC

Offering
$10.8M
Sold
$10.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Shravan Parsi · Austin, TXDirectorJeffery Birch · Chicago, ILExec · DirectorAmir Nashat · CAMBRIDGE, MADirectorPaul Shufro · Wilton, CTDirectorYaron Naymark · Westport, CTExec · DirectorSarah Romano · Waltham, MAExecRichard Young · CAMBRIDGE, MAExecJustin Jory · Woodbridge, VADirectorJosh Mandel-Brehm · CAMBRIDGE, MAExec · DirectorAron Shapiro · Waltham, MADirectorStephen From · Waltham, MAExec · DirectorMatthew Wampler · COLLEGEVILLE, PADirectorBrian Strem · Waltham, MAExec · DirectorRodney D. Brown · LEESBURG, VAExec · DirectorPaul Chaney · Waltham, MADirectorDavid Wurtzbacher · Woodbridge, VAExecDaniel Kapnick · Chicago, ILDirectorPaula Ragan · CAMBRIDGE, MADirectorKenneth Gayron · Waltham, MADirectorRandy H. Hopkins · Meridian, IDDirectorPraveen Tyle · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗